151 related articles for article (PubMed ID: 37324190)
21. LncRNA-p21 suppresses cell proliferation and induces apoptosis in gastric cancer by sponging miR-514b-3p and up-regulating ARHGEF9 expression.
Ma X; Yan W; Xu P; Ma L; Zan Y; Huang L; Wang G; Liu L; Hui W
Biol Chem; 2022 Sep; 403(10):945-958. PubMed ID: 35947460
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA p53 upregulated regulator of p53 levels (PURPL) promotes the development of gastric cancer.
Cheng Z; Hong J; Tang N; Liu F; Gu S; Feng Z
Bioengineered; 2022 Jan; 13(1):1359-1376. PubMed ID: 35012438
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MIR155HG induces M2 macrophage polarization and drug resistance of colorectal cancer cells by regulating ANXA2.
Zhou L; Li J; Liao M; Zhang Q; Yang M
Cancer Immunol Immunother; 2022 May; 71(5):1075-1091. PubMed ID: 34562123
[TBL] [Abstract][Full Text] [Related]
24. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.
Fu T; Ji K; Jin L; Zhang J; Wu X; Ji X; Fan B; Jia Z; Wang A; Liu J; Bu Z; Ji J
Gastric Cancer; 2021 Jan; 24(1):45-59. PubMed ID: 32572790
[TBL] [Abstract][Full Text] [Related]
25. LncRNA FAM230B Promotes Gastric Cancer Growth and Metastasis by Regulating the miR-27a-5p/TOP2A Axis.
Cui Y; Pu R; Ye J; Huang H; Liao D; Yang Y; Chen W; Yao Y; He Y
Dig Dis Sci; 2021 Aug; 66(8):2637-2650. PubMed ID: 32910366
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression.
Zhu W; Tan L; Ma T; Yin Z; Gao J
Dig Liver Dis; 2022 Nov; 54(11):1573-1582. PubMed ID: 35354542
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer.
Zheng J; Zhang H; Ma R; Liu H; Gao P
Oncogene; 2019 Nov; 38(45):7073-7088. PubMed ID: 31409899
[TBL] [Abstract][Full Text] [Related]
28. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
Tao M; Zhou Y; Jin Y; Pu J
Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
[TBL] [Abstract][Full Text] [Related]
29. HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis.
Liang L; Kang H; Jia J
Cell Cycle; 2021 Jun; 20(11):1080-1090. PubMed ID: 33993846
[TBL] [Abstract][Full Text] [Related]
30. LncRNA LOC285194 modulates gastric carcinoma progression through activating Wnt/β-catenin signaling pathway.
Zhong B; Wang Q; He J; Xiong Y; Cao J
Cancer Med; 2020 Mar; 9(6):2181-2189. PubMed ID: 31991056
[TBL] [Abstract][Full Text] [Related]
31. LncRNA PCAT18/miR-301a/TP53INP1 axis is involved in gastric cancer cell viability, migration and invasion.
Dou J; Tu D; Zhao H; Zhang X
J Biochem; 2020 Nov; 168(5):547-555. PubMed ID: 32687182
[TBL] [Abstract][Full Text] [Related]
32. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis.
Xu Y; Zhang G; Zou C; Zhang H; Gong Z; Wang W; Ma G; Jiang P; Zhang W
Cell Physiol Biochem; 2018; 46(6):2445-2459. PubMed ID: 29742512
[TBL] [Abstract][Full Text] [Related]
33. LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p.
Liu L; Dai A; Zhang Z; Ning M; Han D; Li L; Li Z
Aging (Albany NY); 2021 Sep; 13(17):21191-21201. PubMed ID: 34496348
[TBL] [Abstract][Full Text] [Related]
34. LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis.
Liu R; Yang X
BMC Cancer; 2021 Oct; 21(1):1163. PubMed ID: 34715819
[TBL] [Abstract][Full Text] [Related]
35. MiR-139-5p negatively regulates PMP22 to repress cell proliferation by targeting the NF-κB signaling pathway in gastric cancer.
Hou J; Zhuo H; Chen X; Cheng J; Zheng W; Zhong M; Cai J
Int J Biol Sci; 2020; 16(7):1218-1229. PubMed ID: 32174796
[TBL] [Abstract][Full Text] [Related]
36. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer.
Zhang G; Li S; Lu J; Ge Y; Wang Q; Ma G; Zhao Q; Wu D; Gong W; Du M; Chu H; Wang M; Zhang A; Zhang Z
Mol Cancer; 2018 May; 17(1):87. PubMed ID: 29720189
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis.
Li C; Zhang J; Zhou Y; Li B
Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874
[TBL] [Abstract][Full Text] [Related]
38. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer.
YiRen H; YingCong Y; Sunwu Y; Keqin L; Xiaochun T; Senrui C; Ende C; XiZhou L; Yanfan C
Mol Cancer; 2017 Nov; 16(1):174. PubMed ID: 29162158
[TBL] [Abstract][Full Text] [Related]
40. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
